Income-related inequity in initiation of evidence-based therapies among patients with acute myocardial infarction

Journal of General Internal Medicine

Volumn 26, Issue 11, 2011, Pages 1329-1335

  Hanley, Gillian E ^a   Morgan, Steve ^a   Reid, Robert J ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b GROUP HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

access to care; cardiovascular disease; pharmaceutical care; socioeconomic factors

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE DISPARITY; HOSPITAL DISCHARGE; HUMAN; INCOME; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRESCRIPTION; SURVIVAL;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BRITISH COLUMBIA; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; EVIDENCE-BASED MEDICINE; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCOME; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; SEX FACTORS; SOCIAL CLASS;

EID: 80755139587     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-011-1799-1     Document Type: Article

References (41)

1. DA Alter CD Naylor P Austin JV Tu 1999 Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction N Engl J Med 341 18 1359 1367 10536129 10.1056/NEJM199910283411806 1:STN:280:DyaK1MvltV2itA%3D%3D (Pubitemid 29503576)
2. L Pilote L Joseph P Bélisle J Penrod 2003 Universal health insurance coverage does not eliminate inequities in access to cardiac procedures after acute myocardial infarction Am Heart J 146 6 1030 1037 14660995 10.1016/S0002-8703(03)00448-4 (Pubitemid 37500777)
3. DA Alter CD Naylor PC Austin BT Chan JV Tu 2003 Geography and service supply do not explain socioeconomic gradients in angiography use after acute myocardial infarction CMAJ 168 3 261 264 12566329 (Pubitemid 36205191)
4. R Gnavi A Migliardi M Demaria A Petrelli A Caprioglio G Costa 2007 Statins prescribing for the secondary prevention of ischaemic heart disease in torino, italy. A case of ageism and social inequalities Eur J Pub Health 17 5 492 496 10.1093/eurpub/ckm005 (Pubitemid 350033999)
5. EM Antman M Hand PW Armstrong, et al. 2008 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association task force on practice guidelines: Developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 writing group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction, writing on behalf of the 2004 writing committee Circulation 117 2 296 329 18071078 10.1161/CIRCULATIONAHA.107.188209
6. H Dalal PH Evans JL Campbell 2004 Recent developments in secondary prevention and cardiac rehabilitation after acute myocardial infarction BMJ 328 7441 693 697 15031243 10.1136/bmj.328.7441.693 (Pubitemid 38393412)
7. SC Smith Jr J Allen SN Blair, et al. 2006 AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: Endorsed by the National Heart, Lung, and Blood Institute J Am Coll Cardiol 47 10 2130 2139 16697342 10.1016/j.jacc.2006.04.026 (Pubitemid 44275145)
8. MD Flather S Yusuf L Køber, et al. 2000 Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients The Lancet 355 9215 1575 1581 10.1016/S0140-6736(00)02212-1 1:CAS:528:DC%2BD3cXjs1GlurY%3D (Pubitemid 30240501)
9. N Freemantle J Cleland P Young J Mason J Harrison 1999 Beta blockade after myocardial infarction: Systematic review and meta regression analysis BMJ 318 7200 1730 1737 10381708 1:STN:280:DyaK1MzhtVOhuw%3D%3D (Pubitemid 29290470)
10. JC LaRosa J He S Vupputuri 1999 Effects of statins on risk of coronary disease: A meta-analysis of randomized controlled trials JAMA 282 2340 2346 10612322 10.1001/jama.282.24.2340 1:CAS:528:DC%2BD3cXjsF2ntQ%3D%3D (Pubitemid 30013066)
11. ME van der Elst ML Bouvy CJ de Blaey A de Boer 2007 Effect of drug combinations on admission for recurrent myocardial infarction Heart 93 10 1226 1230 17502329 10.1136/hrt.2006.098053 (Pubitemid 47492909)
12. PC Austin JV Tu DT Ko DA Alter 2008 Use of evidence-based therapies after discharge among elderly patients with acute myocardial infarction CMAJ 179 9 895 900 18936454 10.1503/cmaj.071481
13. SL Daugherty PM Ho JA Spertus, et al. 2008 Association of early follow-up after acute myocardial infarction with higher rates of medication use Arch Intern Med 168 5 485 491 18332293 10.1001/archinte.168.5.485 (Pubitemid 351547211)
14. McGrail KM. Equity in health, health care services use and health care financing in British Columbia, 1992 and 2002 [dissertation]. University of British Columbia; 2006.
15. A Wagstaff E van Doorslaer H van der Burg, et al. 1999 Equity in the finance of health care: Some further international comparisons J Health Econ 18 3 263 292 10537896 10.1016/S0167-6296(98)00044-7 1:STN:280:DyaK1Mzhsl2jtg%3D%3D (Pubitemid 29242813)
16. S Morgan M Coombes 2006 Income-based drug coverage in British Columbia: Towards an understanding of the policy Healthcare Policy 2 2 92 108 19305707
17. GE Hanley S Morgan J Hurley E van Doorslaer 2008 Distributional consequences of the transition from age-based to income-based prescription drug coverage in British Columbia, Canada Health Econ 17 12 1379 1392 18189226 10.1002/hec.1337
18. Population Data BC. 2010 Population Data BC website. Available at: http://www.popdata.bc.ca/. Accessed June 22, 2011.
19. CTT Tran A Laupacis MM Mamdani JV Tu 2004 Effect of age on the use of evidence-based therapies for acute myocardial infarction Am Heart J 148 5 834 841 15523314 10.1016/j.ahj.2003.11.028
20. PharmaNet. Available at: http://www.health.gov.bc.ca/pharmacare/ pharmanet/netindex.html. Accessed June 22, 2011.
21. ATC structure and principles. Available at: http://www.whocc.no/atc/ structure-and-principles/. Accessed June 22, 2011.
22. Williams JI, Young W. Inventory of studies on the accuracy of Canadian health administrative databases. 1996.
23. JP Weiner BH Starfield DM Steinwachs LM Mumford 1991 Development and application of a population-oriented measure of ambulatory care case-mix Med Care 29 5 452 472 1902278 10.1097/00005650-199105000-00006 1:STN:280: DyaK3M3htFCgtA%3D%3D
24. GE Hanley S Morgan RJ Reid 2010 Explaining prescription drug use and expenditures using the adjusted clinical groups case-mix system in the population of British Columbia, Canada Med Care 48 5 402 408 20393369 10.1097/MLR.0b013e3181ca3d5d
25. GE Hanley S Morgan 2008 On the validity of area-based income measures to proxy household income BMC Health Serv Res 8 79 85 18402681 10.1186/1472-6963-8- 79 (Pubitemid 351641951)
26. DP Goldman GF Joyce Y Zheng 2007 Prescription drug cost sharing JAMA 298 1 61 69 17609491 10.1001/jama.298.1.61 1:CAS:528:DC%2BD2sXovF2rs78%3D (Pubitemid 47026771)
27. A Austvoll-Dahlgren M Aaserud GE Vist, et al. 2008 Pharmaceutical policies: Effects of cap and co-payment on rational drug use Cochrane Database Syst Rev 1 1 1 127
28. BL Harris A Stergachis LD Ried 1990 The effect of drug co-payments on utilization and cost of pharmaceuticals in a health maintenance organization Med Care 28 10 907 917 2232921 10.1097/00005650-199010000-00005 1:STN:280:DyaK3M%2FktFSguw%3D%3D
29. Hux JE, Fielding DA. The ontario drug benefit program copayment: Its impact on access for ontario seniors and charges to the program. Institute for Evaluative Sciences. 1997.
30. SB Soumerai J Avorn D Ross-Degnan S Gortmaker 1987 Payment restrictions for prescription drugs under Medicaid N Engl J Med 317 9 550 556 3302713 10.1056/NEJM198708273170906 1:STN:280:DyaL2s3oslWgsQ%3D%3D
31. SB Soumerai TJ McLaughlin D Ross-Degnan CS Casteris P Bollini 1994 Effects of limiting medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia N Engl J Med 331 10 650 655 8052275 10.1056/NEJM199409083311006 1:STN:280:DyaK2czivFWgtA%3D%3D (Pubitemid 24276866)
32. R Tamblyn R Laprise JA Hanley, et al. 2001 Adverse events associated with prescription drug cost-sharing among poor and elderly persons JAMA 285 4 421 429 11242426 10.1001/jama.285.4.421 1:STN:280:DC%2BD3M7nvVKitA%3D%3D (Pubitemid 32097260)
33. EW Brian SF Gibbens 1974 California's medical copayment experiment Med Care 12 12 suppl 1 303 4612264 1:STN:280:DyaE2M%2Fmt12nsA%3D%3D
34. JN Rasmussen GH Gislason S Rasmussen, et al. 2007 Use of statins and beta-blockers after acute myocardial infarction according to income and education J Epidemiol Community Health 61 12 1091 1097 18000133 10.1136/jech.2006.055525 (Pubitemid 350207367)
35. H Ohlsson M Rosvall O Hansen B Chaix J Merlo 2010 Socioeconomic position and secondary preventive therapy after an AMI Pharmacoepidemiol Drug Saf 19 4 358 366 20087850
36. M Chernew TB Gibson K Yu-Isenberg MC Sokol AB Rosen AM Fendrick 2008 Effects of increased patient cost sharing on socioeconomic disparities in health care J Gen Intern Med 23 8 1131 1136 18443882 10.1007/s11606-008-0614-0
37. AS Adams SB Soumerai D Ross-Degnan 2001 Use of antihypertensive drugs by medicare enrollees: Does type of drug coverage matter Health Aff 20 1 276 286 10.1377/hlthaff.20.1.276 1:STN:280:DC%2BD3M7gtVCrsg%3D%3D (Pubitemid 33710271)
38. AD Federman AS Adams D Ross-Degnan SB Soumerai JZ Ayanian 2001 Supplemental insurance and use of effective cardiovascular drugs among elderly medicare beneficiaries with coronary heart disease JAMA 286 14 1732 1739 11594898 10.1001/jama.286.14.1732 1:STN:280:DC%2BD3Mrmt1SmtQ%3D%3D (Pubitemid 33010259)
39. M Heisler H Choi AB Rosen, et al. 2010 Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: A longitudinal analysis Med Care 48 2 87 94 20068489
40. S Gerward P Tydén O Hansen G Engström L Janzon B Hedblad 2006 Survival rate 28 days after hospital admission with first myocardial infarction. inverse relationship with socio-economic circumstances J Intern Med 259 2 164 172 16420545 10.1111/j.1365-2796.2005.01594.x 1:STN:280: DC%2BD28%2FjtlCgsw%3D%3D
41. IA Dhalla MA Smith NK Choudhry AE Denbur 2009 Costs and benefits of free medications after myocardial infarction Healthcare Policy 5 2 68 86 21037827